Letter
No access
Published Online: 10 February 2021

Conversion of Existing UVB Phototherapy Units to UVC Germicidal Chambers for N95 Decontamination: Lessons Learned

Publication: Photobiomodulation, Photomedicine, and Laser Surgery
Volume 39, Issue Number 2
First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

References

1. Hamzavi IH, Lyons AB, Kohli I, et al. Ultraviolet germicidal irradiation: possible method for respirator disinfection to facilitate reuse during the COVID-19 pandemic. J Am Acad Dermatol 2020;82:1511–1512.
2. Mills D, Harnish DA, Lawrence C, Sandoval-Powers M, Heimbuch BK. Ultraviolet germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators. Am J Infect Control 2018;46:e49–e55.
5. UV series: full body surround. Daavlin. 2020. Available at: www.daavlin.com/patients/phototherapy-products/uv-series-full-body-surround/ (Last accessed October 15, 2020).

Information & Authors

Information

Published In

cover image Photobiomodulation, Photomedicine, and Laser Surgery
Photobiomodulation, Photomedicine, and Laser Surgery
Volume 39Issue Number 2February 2021
Pages: 83 - 85
PubMed: 33481669

History

Published online: 10 February 2021
Published in print: February 2021
Published ahead of print: 21 January 2021
Accepted: 11 December 2020
Received: 17 October 2020

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Bina Kassamali*
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Zizi Yu*
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Christopher Davis
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Mary Carmack
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Ai-Tram N. Bui
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jordan T. Said
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Deborah Plana
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Harvard-MIT Division of Health Sciences & Technology Program, Cambridge, Massachusetts, USA.
Helen Yang
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Peter Sorger
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts, USA.
Nicole R. LeBoeuf [email protected]
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Avery H. LaChance
Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Notes

*
These authors contributed equally.
Co-senior authors.
Address correspondence to: Nicole R. LeBoeuf, MD, MPH, Department of Dermatology, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA 02115, USA [email protected]

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top